Sulbactam sodium and dulobactam sodium/sulbactam-durobactam (Xacduro) price information and detailed explanation of purchase methods

Sulbactam sodium and dulobactam sodium (Xacduro) are an innovative antibiotic combination drug designed to treat specific serious bacterial infections , mainly targeting hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by sensitive strains of Acinetobacter baumannii-calcium acetate complex. These infections often occur in patients with pre-existing serious medical conditions, and treatment with conventional antibiotics is often of limited effectiveness due to increased bacterial resistance in these patients.

Xacduro is composed of sulbactam sodium and dulobactam sodium. These two ingredients work synergistically to effectively inhibit the activity of beta-lactamase, thereby enhancing the antibiotic's bactericidal ability against drug-resistant Acinetobacter baumannii. This unique mechanism allows Xacduro to demonstrate significant efficacy in treating such serious and difficult-to-treat infections.

Since Xacduro has been widely used around the world since it was approved for marketing by the U.S. Food and Drug Administration (FDA) in 2023. Its efficacy and safety have been verified by multiple clinical studies, including the landmark Phase 3 clinical ATTACK study, which demonstrated that Xacduro is statistically non-inferior compared to traditional therapies in the safety and efficacy of polymyxin E in the treatment of patients with Acinetobacter infection.

In addition,The launch of Xacduro has also undergone strict regulatory approval procedures, including priority review and approval by the China National Medical Products Administration (NMPA), ensuring its legality and safety in the Chinese market. At present, sulbactam sodium and dulobactam sodium have been officially launched in China. Patients in need can purchase it directly at domestic hospitals at a price of about 400 yuan.

In summary, sulbactam sodium and dulobactam sodium (Xacduro) provides a new and effective solution for the treatment of drug-resistant Acinetobacter baumannii infections, bringing new treatment hope and better quality of life to patients.

Reference: https://www.drugs.com/xacduro.html